ADYNOVATE

Google image searchProduct monograph

Active ingredient

antihemophilic factor (recombinant), pegylated, 1500 UNIT/VIAL

DIN: 02498596

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: 750 UNITS/ML (2 ML DILUENT) - SINGLE USE VIAL

Schedule: Schedule D

Company: TAKEDA CANADA INC

Date: 27-AUG-2021

ATC:

• B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
• B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
• B02BD — Blood coagulation factors (ATC, ATC/DDD)
• B02BD02 — COAGULATION FACTOR VIII (ATC/DDD)

Reference brand drug: Adynovate, Eloctate, Esperoct, Jivi, Kovaltry, Nuwiq, Obizur, Xyntha, Zonovate

External Links for Adynovate

Search on Google

• Adynovate side effects
• Adynovate dosage
• antihemophilic factor side effects
• antihemophilic factor dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find adynovate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.